To include your compound in the COVID-19 Resource Center, submit it here.

Cancer

INDICATION: Breast cancer; colorectal cancer

Mouse studies suggest combining inhibitors of TGFβ signaling with anti-PD-L1 therapies could help treat breast and colorectal cancers. In a mouse model of breast

Read the full 289 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE